Explore the ways in which AI will transform healthcare, biotech, and medicine through conversations with entrepreneurs, investors and scientists. Hosted by Pranav Rajpurkar and Adriel Saporta. Produced by Oishi Banerjee and Marc Robbins.
Harvard's Dr. George Church on Aging Reversal, Woolly Mammoths, and the Future of Genomics
Dr. George Church is a Professor of Genetics at Harvard Medical School and a co-founder of multiple biotech companies. In this wide-ranging interview, he speaks about his work on de-extinction, his vision of a future without age-related illness, and his AI-powered startups.
How Academia Can Make an Impact: University of Michigan's Dr. Karandeep Singh on Deployment and Evaluation
Karandeep Singh, MD, MMSc, is an Assistant Professor of Learning Health Sciences, Internal Medicine, Urology, and Information at the University of Michigan. He speaks with us about bridging the gap between academia and practice and discusses how the University of Michigan deploys and rigorously evaluates machine learning models in real clinical practice.
Immunai's Luis Voloch on Industrial-Scale Immunology
Luis Voloch is Co-Founder and Chief Technology Officer at Immunai, which is applying AI to immunology, genomics and drug discovery. He speaks with us about how Immunai is using AI to build a comprehensive, top-of-the-tree view of the immune system.
Changemakers and Truth-Seekers: Johns Hopkins's Dr. Suchi Saria on Bayesian Health
Dr. Suchi Saria is the Founder and CEO of Bayesian Health, the John C. Malone Associate Professor of computer science, statistics, and health policy, and the Director of the Machine Learning and Healthcare Lab at Johns Hopkins University. She speaks with us on how Bayesian Health uses insights from electronic health records to detect diseases and improve patient outcomes.
Medical (Incentives) Engineering: Harvard's Dr. Trishan Panch on Wellframe, Research and Entrepreneurship
Dr. Panch is a primary care physician, the Co-Founder of Wellframe, and an instructor at the Harvard T.H. Chan School of Public Health. He speaks with us about Wellframe's work on demystifying complex care regimens, providing personalized support to patients, and understanding social issues affecting healthcare. He also discusses entrepreneurship strategies, the role of academic research, and the future of medical AI regulation.
The Medical AI 2x2: GV’s Dr. Krishna Yeshwant on Market Positioning and Investing
Dr. Krishna Yeshwant is Managing Partner of GV. In addition to working with GV since its inception, he has earned degrees in computer science, medicine and business, and he practiced at Brigham and Women’s Hospital in Boston, Massachusetts for several years. He speaks with us about different segments of the healthcare market and the role of investors in improving medicine.
Great guests, I always come away with some thoughts to ponder for a few days and build off of. I often get to the end of an episode and wish they were longer and dug deeper into certain topics. Which is a good sign!
Empowering and Inspirational
I picked this podcast up over the pandemic in my senior year of college hunting for jobs. It was a really tough time for me, but Pranav and Adriel showed me that there is so much more out there than I could have ever imagined. Hearing other people’s career trajectories and their journeys changed my own career trajectory and pushed me to get my masters in Machine Learning. I’m extremely grateful to have found this podcast. I would definitely recommend giving it a listen, especially if you are a student.
Super rich in content!